CDC report highlights the gaps in care of hepatitis C treatment

The prevalence of hepatitis C virus clearance was only 34% overall and even lower in individuals between 20 and 39 years of age.

Shielding The Healthcare Ecosystem from Ongoing Cyberattacks

Vaibhav Srivastava, President of Healthcare, Insurance and Life Sciences (HILS), Innova Solutions In today’s growing cyber-attack landscape, hospital systems have quickly become the prime target

October 1, 2024

What led to a decline in US breast cancer mortality between 1975 and 2019?

Breast cancer mortality rates among United States (US) women aged 30-79 years between 1975 and 2019.

January 17, 2024

BRAIN Biotech AG signs exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology with Akribion Therapeutics GmbH for up to EUR 92.3 million milestone fees plus royalties – Biotech Investments

BRAIN Biotech AG / Key word(s): Contract BRAIN Biotech AG signs exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology with Akribion Therapeutics GmbH for

November 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.